Home > Financial Ratios > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 30.8923.5130.6732.8027.18

What is the latest EV/Core EBITDA ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 30.89 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202430.89
Mar202323.51
Mar202230.67
Mar202132.80
Mar202027.18

How is EV/Core EBITDA of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 30.89
31.39
Mar2023 23.51
-23.35
Mar2022 30.67
-6.49
Mar2021 32.8
20.68
Mar2020 27.18 -

Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹48,238.3 Cr -3.8% 2.6% 35% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,406.0 Cr -2.7% 3.9% 19.8% Stock Analytics
DIVIS LABORATORIES ₹163,113.0 Cr 1% 8.5% 55.3% Stock Analytics
CIPLA ₹121,869.0 Cr -2.6% 3.9% 6.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹111,345.0 Cr -0.7% 2.5% 22.3% Stock Analytics
DR REDDYS LABORATORIES ₹96,801.0 Cr -1.9% 0.9% -7.8% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-3.8%

2.6%

35%

SENSEX

0.6%

6.2%

8.4%


You may also like the below Video Courses